Antimicrobial resistance, the global shortage of medicines and vaccines and the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPOA) were top themes debated during the 70th World Health Assembly this May. The MPP addressed delegates on each of these topics, welcoming expanded efforts to prevent and control drug resistance in HIV and tuberculosis and underscoring the importance of innovation, access and proper stewardship of new antibiotics. The foundation highlighted its commitment to patent status transparency, a key GSPOA recommendation. Representatives from the MPP also briefed Member States on its feasibility study exploring an expanded role for the organisation in improving access to patented essential medicines.
Read MPP’s interventions on antimicrobial resistance, on the evaluation and review of the global strategy and plan of action on public health, innovation and intellectual property, and on addressing the global shortage of, and access to, medicines and vaccines.